Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production

被引:85
作者
Young, JM [1 ]
Panah, S [1 ]
Satchawatcharaphong, C [1 ]
Cheung, PS [1 ]
机构
[1] SYNTEX INC,DISCOVERY RES,INST IMMUNOL & BIOL SCI,PALO ALTO,CA 94304
关键词
NSAID; PGHS-1; PGHS-2; A23187; lipopolysaccharide;
D O I
10.1007/BF02259611
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When freshly drawn, heparinized human whole blood is incubated with 50 mu M calcium ionophore A23187, platelets are stimulated to produce thromboxane B-2 (TxB(2)) by activation of prostaglandin G/H synthase-1 (PGHS-1). TxB(2) concentration, as measured by immunoassay, is maximal at 20-30 min and declines thereafter. Addition of acetysalicylic acid (IC50=2.8 mu M) or other nonsteroidal antiinflammatory drugs (NSAIDs) 15 min or 4.5 h prior to 30 min stimulation with ionophore results in concentration dependent inhibition of TxB(2) production. When blood is incubated with 0.01-10 mu g/ml E. coli lipopolysaccharide (LPS), PGHS-2 is induced and TxB(2) levels become detectable at 3 h and continue to increase through 24 h. Using a 5 h incubation with 10 mu g/ml LPS, aspirin (10 mu M added at 0 h), which is rapidly metabolized to salicylic acid, had no effect on 10 mu g/ml LPS-induced TxB(2), but inhibited TxB(2) production by ionophore A23187 added at 4.5 h, through acetylation of preexisting PGHS-1. In a 5 h assay, NSAIDs added at 0 h were compared for inhibition of TxB2 production stimulated by addition of ionophore A23187 at 4.5 h (PGHS-1), or by addition of LPS at 0 h (PGHS-2). Most NSAIDs were more potent against PGHS-1 than PGHS-2. Diclofenac, naproxen and flufenamic acid were equipotent or slightly selective for PGHS-2. Diflunisal and nimesulide were >4-fold selective for PGHS-2, and NS-398 was >30-fold selective for PGHS-2.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 25 条
[1]   PURIFICATION, CHARACTERIZATION AND SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN-G/H SYNTHASE-1 AND SYNTHASE-2 EXPRESSED IN THE BACULOVIRUS SYSTEM [J].
BARNETT, J ;
CHOW, J ;
IVES, D ;
CHIOU, M ;
MACKENZIE, R ;
OSEN, E ;
NGUYEN, B ;
TSING, S ;
BACH, C ;
FREIRE, J ;
CHAN, H ;
SIGAL, E ;
RAMESHA, C .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (01) :130-139
[2]   CLONING 2 ISOFORMS OF RAT CYCLOOXYGENASE - DIFFERENTIAL REGULATION OF THEIR EXPRESSION [J].
FENG, L ;
SUN, WQ ;
XIA, YY ;
TANG, WW ;
CHANMUGAM, P ;
SOYOOLA, E ;
WILSON, CB ;
HWANG, D .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 307 (02) :361-368
[3]  
FLETCHER BS, 1992, J BIOL CHEM, V267, P4338
[4]  
FU JY, 1990, J BIOL CHEM, V265, P16737
[5]   NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO [J].
FUTAKI, N ;
TAKAHASHI, S ;
YOKOYAMA, M ;
ARAI, I ;
HIGUCHI, S ;
OTOMO, S .
PROSTAGLANDINS, 1994, 47 (01) :55-59
[6]   ETODOLAC SELECTIVELY INHIBITS HUMAN PROSTAGLANDIN-G/H-SYNTHASE-2 (PGHS-2) VERSUS HUMAN PGHS-1 [J].
GLASER, K ;
SUNG, ML ;
ONEILL, K ;
BELFAST, M ;
HARTMAN, D ;
CARLSON, R ;
KREFT, A ;
KUBRAK, D ;
HSIAO, CL ;
WEICHMAN, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :107-111
[7]  
GLASER KB, 1995, INFLAMM RES S3, V44, pS276
[8]   INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE ACTIVITY IN HUMAN PLATELETS AND MONONUCLEAR-CELLS BY NSAIDS AND COX-2 INHIBITORS [J].
GROSSMAN, CJ ;
WISEMAN, J ;
LUCAS, FS ;
TREVETHICK, MA ;
BIRCH, PJ .
INFLAMMATION RESEARCH, 1995, 44 (06) :253-257
[9]   LIPOPOLYSACCHARIDE INDUCES PROSTAGLANDIN-H SYNTHASE-2 PROTEIN AND MESSENGER-RNA IN HUMAN ALVEOLAR MACROPHAGES AND BLOOD MONOCYTES [J].
HEMPEL, SL ;
MONICK, MM ;
HUNNINGHAKE, GW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :391-396
[10]   HUMAN CYCLOOXYGENASE-2 CDNA [J].
HLA, T ;
NEILSON, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7384-7388